Azitra Inc
Veridion Score
Composite trend over time
Why is AZTR moving today?
Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for AZTR.
AZTR insider activity
Azitra Inc
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for AZTR.
AZTR contract awards, year to date.
Public federal awards linked to this ticker.
AZTR lobbying filings, year to date.
Registered lobbying filings matched to Azitra Inc.